Immunotherapy drugs can be more effective against cancer when combined with other therapies, such as radiation therapy, targeted drugs, or other immunotherapy agents. Clinical trials that are currently underway are testing such combinations in a variety of cancers.
Charlie Benoit was told that he had a long road ahead of him when he was diagnosed with glioblastoma in 2011. More than seven years later, he's still doing well — and by studying patients like Benoit, researchers hope to help other patients with this incurable form of brain cancer.
Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative "active surveillance" strategy. Conservative management of low-risk prostate cancer is associated with a very favorable prognosis.
In December 2018, tagraxofusp became the first drug ever approved by the U.S. Food and Drug Administration for treatment of blastic plasmacytoid dendritic cell neoplasm, a very aggressive blood cancer. The drug is a new standard of care for the disease.
We are committed to providing the most advanced and compassionate care possible. First appointments are often available within 24 hours. Connect online or call 866-705-0122 (adult patients) or 877-689-0699 (pediatric patients).
The Dana-Farber Care Card is a reloadable spending card for patients, family members, friends, staff, and other visitors to make cashless purchases for food and services. Buy a Care Card
SAVE THE DATE
Fit and Strong
Tuesday, February 26, 2019 11:10 a.m. – 12:00 p.m. Zakim Center This class focuses on strengthening the whole body using a variety of equipment including dumbbells, tubing, or stability balls. Events calendar
Rally Against Cancer on Red Sox Opening Day
Tuesday, April 9, 2019 Your workplace or school Support Rally Against CancerSM presented by Chowdaheadz by giving $10+ to the Jimmy Fund, and wear Sox gear to work or school on April 9. Learn more
HOW TO HELP
Boston Marathon® Jimmy Fund Walk presented by Hyundai
Walk to conquer cancer on Sunday, September 22, and make a difference in the lives of cancer patients. Register
Pan-Mass Challenge, August 3-4, 2019
Join thousands of riders for the 40th PMC and help the PMC reach its $58 million goal for cancer research at Dana-Farber. Register today
